COVID-19 pandemic highlights the acute need to develop fast, on-demand therapeutics against pathogens and health threats. Traditional approaches to drug development are expensive, too slow to react to pandemics like COVID-19. AI tools on the other hand have the potential to accelerate and transform this effort, enabling rapid, large scale search and identification of effective candidates for therapeutics. To translate this potential to success, we believe we must bring together researchers in computational and life sciences. While these communities are today closer than ever, we still sometimes speak different languages. The goal of this website is to lower the barrier for people from varied backgrounds to get involved and contribute to our shared, global goal.